Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Side Effects to be Discovered more Quickly, Leading to Safer Prescribing

Published: Monday, April 15, 2013
Last Updated: Monday, April 15, 2013
Bookmark and Share
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.

The module will support healthcare professionals know how and when to report side effects of medications – an essential element of patient safety.

Drug side effects are a major public health concern worldwide and are amongst the leading cause of death in many countries. Although no medicine is ever completely free of risk, the World Health Organization estimates that at least 60% of adverse drug reactions are preventable.

Effective reporting of drug reactions is an important way for healthcare professionals to contribute to the safer use of medicines. In the UK, this is done by completing a Yellow Card and submitting it to the MHRA. This is a quick and easy process, and can be done online or by post.

Although this Yellow Card scheme provides valuable information, its effectiveness is limited by under-reporting. Busy healthcare workers may mistakenly assume that reporting is a time consuming and complicated process, or that the information they have is not useful.

This module will help to change that view. After completing the module, healthcare professionals will understand the importance of continuous monitoring for adverse drug effects, know which type of situation should trigger a report through the Yellow Card scheme, and be able to fill out a Yellow Card correctly.

They should also know where to find up-to-date information on adverse effects of drugs, and be able to use that information to make safe prescribing choices.

One doctor who completed the module said: "Interesting and very relevant. Will encourage me to adverse report more often.” Another commented: “Very simple to follow. Good videos. Useful - will pay more attention to yellow cards from now on."

Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA said: "The education module that has been developed has been written for healthcare professionals who routinely make decisions about prescribing, supplying or administering medicines. We hope it provides a useful tool in professional development and increasing understanding of the role of healthcare professionals in contributing to the knowledge and understanding of the risks and side-effects of medicines. This in turn should help in making treatment choices with patients."

Dr Kieran Walsh, Clinical Director of BMJ Learning, said: "Adverse side effects to new or old drugs happen all the time, but they are not reported as often as they should be to the correct authorities. This module explains to all healthcare professionals how to do this. It is an important guide to help everyone improve their performance in this essential component of patient safety."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UK Moves Towards Safe and Effective Electronic Cigarettes and Other NCPs
All nicotine-containing products, such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.
Friday, July 12, 2013
MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
Man Jailed in Pre-Clinical Trial Data Scam Case
The man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
Friday, April 19, 2013
Warning Over Potentially Toxic Chinese Herbal Medicine
MHRA warn people not to use Zheng Tian Wan to treat migraines.
Thursday, April 18, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website
Tuesday, September 09, 2008
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos